04 Oct 2024
Agent of change: modern PCI with DCB
Sponsored by Boston Scientific
Anchorperson:
H. C. Tan
Summary
Discover the power of drug-coated balloon (DCB) technology in modern PCI. Understand the mechanism of action, including antiproliferative agents, drug transfer to the vessel wall, and effective inhibitory level and duration of vessel wall retention. Learn how IVUS can guide optimal lesion preparation, and explore the criteria for delivering effective DCB treatment.
Learning Objectives
- To understand drug coated balloon (DCB) technology (including antiproliferative agents, drug transfer to vessel wall, effective inhibitory level and duration of vessel wall retention)
- To learn how IVUS can guide optimal lesion preparation
- To learn the criteria for optimal lesion preparation prior to DCB application
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)
/slide023.jpg)
/slide024.jpg)
/slide025.jpg)
/slide026.jpg)
/slide027.jpg)
/slide028.jpg)
/slide029.jpg)
/slide030.jpg)
/slide031.jpg)
/slide032.jpg)
/slide033.jpg)
/slide034.jpg)
/slide035.jpg)
/slide036.jpg)
/slide037.jpg)
/slide038.jpg)
/slide039.jpg)
/slide040.jpg)
/slide042.jpg)
/slide043.jpg)
/slide044.jpg)
/slide045.jpg)
/slide046.jpg)
/slide047.jpg)
/slide048.jpg)
/slide049.jpg)
/slide050.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)